For weight management, GLP-1 binds central GLP-1 receptors inside hypothalamus to enhance satiety signal, delays gastric emptying and gastrointestinal peristalsis to prolong stomach fullness, naturally reducing daily food intake and cumulative calorie surplus
And honestly, that changes your whole existence
The most prevalent factors employers take into consideration for GLP-1 drug coverage for obesity care include: Obesity as a risk factor for chronic conditions and associated costs67% Drug shortages47% Impact/effectiveness of cost-control mechanisms47% Existing coverage through government programs40% Long-term costs33% Patient and prescriber demand33%
Several preclinical studies
Other options include hydroxychloroquine, sulfasalazine, and leflunomide
Addressing metabolism, sleep, nutrition, and psychiatric treatment together